Canadian astronaut Joshua Kutryk will travel to the International Space Station as part of NASA's SpaceX Crew-13 mission [4].
The mission represents a significant step for the Canadian Space Agency in its efforts to conduct health-focused research and support future lunar exploration. By spending an extended period in orbit, Kutryk will contribute data essential for the Artemis missions, which aim to return humans to the moon.
Kutryk, a colonel and native of Fort Saskatchewan, Alberta, is scheduled to launch in September 2026 [2]. He is expected to spend about six months aboard the station [1]. His primary objectives include performing scientific experiments focused on human health in microgravity, a critical component for long-term space travel.
Ahead of the upcoming mission, Kutryk participated in a media visit to Calgary, Alberta, on May 24-25, 2024 [3]. The visit served as a platform to share insights about the Crew-13 mission and engage with the public regarding Canada's role in international space cooperation.
NASA's SpaceX Crew-13 mission is part of a rotating series of crews that maintain the station's continuous operation. Kutryk's inclusion in the crew highlights the ongoing partnership between the U.S. and Canada in orbital research. The health-focused research he will lead is designed to mitigate the physiological risks associated with long-duration spaceflight, such as muscle loss, and radiation exposure.
As the launch date in September 2026 approaches, Kutryk will undergo rigorous training to prepare for the complexities of the International Space Station environment. This preparation includes simulated missions and technical drills to ensure the safety of the crew and the success of the scientific payloads.
“Joshua Kutryk will travel to the International Space Station as part of NASA's SpaceX Crew-13 mission”
Kutryk's mission serves as a bridge between current low-Earth orbit operations and the deep-space goals of the Artemis program. By focusing on health research, the Canadian Space Agency is positioning itself as a key provider of medical and physiological data necessary for sustaining human life on the moon and eventually Mars.
